DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betoptic Pilo (Betaxolol Hydrochloride / Pilocarpine Hydrochloride) - Published Studies

 
 



Betoptic Pilo Related Published Studies

Well-designed clinical trials related to Betoptic Pilo (Betaxolol / Pilocarpine)

A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma. [1998.08]

Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine. [1996]

Comparison of the postoperative intraocular pressure with Betagan, Betoptic, Timoptic, Iopidine, Diamox, Pilopine Gel, and Miostat. [1992.01]

Well-designed clinical trials possibly related to Betoptic Pilo (Betaxolol / Pilocarpine)

Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. [1997.05]

Unsuspected bronchospasm in association with topical timolol--a common problem in elderly people: can we easily identify those affected and do cardioselective agents lead to improvement? [1994.01]

Improved lung function tests on changing from topical timolol: non-selective beta-blockade impairs lung function tests in elderly patients. [1993]

The effect of topical antiglaucoma drugs on the results of high-pass resolution perimetry. [1991.06.15]

Effect of different antiglaucomatous drugs on ocular perfusion pressures. [1988.09]

Other research related to Betoptic Pilo (Betaxolol / Pilocarpine)

Intraocular pressure reduction with topically administered pilocarpine, timolol and betaxolol in normal tension glaucoma. [1993.10]

Other possibly related research studies

Contact dermatitis to topical drugs for glaucoma. [2001.12]

Brimonidine (Alphagan): a clinical profile four years after launch. [2001.07]

[Additive effects of topical carbonic anhydrase inhibitors] [2001.07]

Bilateral angle closure glaucoma and visual loss precipitated by antidepressant and antianxiety agents in a patient with depression. [2000.09]

Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. [2000.08]

Dorzolamide, a 40-year wait. From an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma. [1998]

Lacrimal canalicular obstruction associated with topical ocular medication. [1998.08]

Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. [1998.03]

Five-year follow-up of treated patients with glaucoma using resolution perimetry. [1998.02]

Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. [1997.05]

Adverse drugs reactions associated with glaucoma medications. [1997.04]

The effects of long-term topical glaucoma medication on conjunctival impression cytology. [1997]

The effect of treatment on the results of high-pass resolution perimetry in glaucoma. [1994.08]

New developments in the drug treatment of glaucoma. [1991.04]

Dosage cost analysis in glaucoma management. [1989.10]

Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results. [1989.08]

Retrospective cohort study of 163 pediatric glaucoma patients. [2009.06]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017